Press ReleaseThe Next Big Upgrade for Augmented Reality Glasses is Here as Market Leader XREAL Brings Largest Field of View and First-of-Their-Kind Modular AR Glasses to CES 2025 XREAL One and XREAL One Pro with X1 chip redefine AR with… CISION PRNewswireJanuary 6, 2025
Press ReleaseENGWE to Unveil New Commuter E-Bike Line "Mapfour" at CES 2025 LOS ANGELES, Jan. 6, 2025 /PRNewswire/ — ENGWE, a leader in fat-tire… CISION PRNewswireJanuary 6, 2025
Technoderma Medicines Completes Positive Ph2a Proof- of Concept Trial with Topical TDM-180935 Ointment for Atopic Dermatitis CHENGDU, China, Jan. 6, 2025 /PRNewswire/ — Technoderma Medicines, Inc. ("the Company"),… CISION PRNewswireJanuary 6, 2025
Press ReleaseBeatbot to Introduce the Amphibious RoboTurtle and Shore Self-Docking & Charging Station at CES 2025 Two Game-Changing Innovations in Smart Pool Care and Environmental Stewardship LAS VEGAS,… CISION PRNewswireJanuary 6, 2025
Press ReleaseNTQ Unveils Brand Transformation and Kickstarts the Global IT Service Provider Vision HANOI, Vietnam, Jan. 6, 2025 /PRNewswire/ — On January 6, NTQ (formerly known… CISION PRNewswireJanuary 6, 2025
Concord Medical Announces Result of 2024 Annual General Meeting BEIJING, Jan. 6, 2025 /PRNewswire/ — Concord Medical Services Holdings Limited ("Concord… CISION PRNewswireJanuary 6, 2025
Press ReleaseTechi2Cool Powers Green Event Management at Hong Kong Coliseum with Electricity-free Cooling Technology HONG KONG, Jan. 6, 2025 /PRNewswire/ — i2Cool, a trailblazer in passive… CISION PRNewswireJanuary 6, 2025
I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody, will be the… CISION PRNewswireJanuary 6, 2025
